Trials / Conditions / Stage III Oral Cavity Squamous Cell Carcinoma
Stage III Oral Cavity Squamous Cell Carcinoma
5 registered clinical trials studyying Stage III Oral Cavity Squamous Cell Carcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Nivolumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carc NCT03342911 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Phase 2 |
| Terminated | Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer NCT02827838 | Wake Forest University Health Sciences | EARLY_Phase 1 |
| Terminated | Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer NCT02388932 | Case Comprehensive Cancer Center | N/A |
| Terminated | Ganetespib Window of Opportunity Study in Head and Neck Cancers NCT02334319 | Emory University | Phase 1 |
| Completed | TPF Induction Chemotherapy for Locally Advanced and Resectable Oral Squamous Cell Carcinoma NCT01542931 | Shanghai Jiao Tong University School of Medicine | Phase 2 / Phase 3 |